Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
- Identifier
-
1206175710
- Beteiligte Personen und Organisationen
-
Giovanella, Luca
Maffioli, Marco
Ceriani, Luca
Palma, Diego De
Spriano, Giuseppe
- DOI
-
10.18452/12946
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Giovanella, Luca
- Maffioli, Marco
- Ceriani, Luca
- Palma, Diego De
- Spriano, Giuseppe
Ähnliche Objekte (12)
Application of the American Thyroid Association risk assessment in patients with differentiated thyroid carcinoma in a German population
I-131-SPECT-CT in the follow-up of patients with differentiated thyroid carcinoma
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
Value of the Estimation of Thyroglobulin Levels in the Surveillance of Treated Differentiated Thyroid Carcinoma
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
New aspects in thyroid diseases : medullary thyroid carcinoma, thyroiditis, peripheral thyroid hormone metabolism
Molecular pathogenesis of papillary thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Effect of metformin on growth of differentiated thyroid cells and thyroid carcinoma cells and their derived cancer stem cells : implication for metformin as adjuvant treatment for undifferentiated thyroid cancer
The course of differentiated thyroid carcinoma in patients in whom the initial I-131 ablative treatment was successful
The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates : a decision-tree-based analysis
Application of the American Thyroid Association risk assessment in patients with differentiated thyroid carcinoma in a German population
I-131-SPECT-CT in the follow-up of patients with differentiated thyroid carcinoma
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
Value of the Estimation of Thyroglobulin Levels in the Surveillance of Treated Differentiated Thyroid Carcinoma
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
New aspects in thyroid diseases : medullary thyroid carcinoma, thyroiditis, peripheral thyroid hormone metabolism
Molecular pathogenesis of papillary thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Effect of metformin on growth of differentiated thyroid cells and thyroid carcinoma cells and their derived cancer stem cells : implication for metformin as adjuvant treatment for undifferentiated thyroid cancer
The course of differentiated thyroid carcinoma in patients in whom the initial I-131 ablative treatment was successful
The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates : a decision-tree-based analysis
Application of the American Thyroid Association risk assessment in patients with differentiated thyroid carcinoma in a German population
I-131-SPECT-CT in the follow-up of patients with differentiated thyroid carcinoma
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
Value of the Estimation of Thyroglobulin Levels in the Surveillance of Treated Differentiated Thyroid Carcinoma
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
New aspects in thyroid diseases : medullary thyroid carcinoma, thyroiditis, peripheral thyroid hormone metabolism
Molecular pathogenesis of papillary thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Effect of metformin on growth of differentiated thyroid cells and thyroid carcinoma cells and their derived cancer stem cells : implication for metformin as adjuvant treatment for undifferentiated thyroid cancer
The course of differentiated thyroid carcinoma in patients in whom the initial I-131 ablative treatment was successful